Ocumetics Receives Ethics Committee Approval for First-In-Human Clinical Study of Accommodating Intraocular Lens
Thenewswire·2025-07-30 13:00
Calgary, Alberta – TheNewswire - July 30, 2025 - Ocumetics Technology Corp. ("Ocumetics" or the "Company") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce that the ethics committee of the clinical site in Mexico City overseeing the first in-human study of the Ocumetics accommodating intraocular lens (the "Ocumetics Lens") has verbally approved the protocol for the study. Formal written approval is expected by August 5, 2025. Dean Burns, CEO of Ocume ...